Time course of inflammation, myocardial injury, and prothrombotic response after radiofrequency catheter ablation for atrial fibrillation

Circulation: Arrhythmia and Electrophysiology

Volumn 7, Issue 1, 2014, Pages 83-89

  Lim, Han S ^a   Schultz, Carlee ^a   Dang, Jerry ^a   Alasady, Muayad ^a   Lau, Dennis H ^a   Brooks, Anthony G ^a   Wong, Christopher X ^a   Roberts Thomson, Kurt C ^a   Young, Glenn D ^a   Worthley, Matthew I ^a   Sanders, Prashanthan ^a   Willoughby, Scott R ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Atrial fibrillation; Catheter ablation; Inflammation; Thrombosis

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE MB; D DIMER; ENOXAPARIN; FIBRINOGEN; PROTHROMBIN; TROPONIN T; WARFARIN; AUTACOID; BIOLOGICAL MARKER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CATHETER ABLATION; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART MUSCLE INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; PRIORITY JOURNAL; PROTEIN BLOTTING; RADIOFREQUENCY ABLATION; RECURRENT DISEASE; VERY ELDERLY; BLOOD; HEART INJURY; INFLAMMATION; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; RISK FACTOR; THROMBOSIS; TIME; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; CATHETER ABLATION; INFLAMMATION; THROMBOSIS;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CATHETER ABLATION; CREATINE KINASE, MB FORM; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HEART INJURIES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; TROPONIN T;

EID: 84898890817     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.113.000876     Document Type: Article

References (23)

1. Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol. 2007;50: 2021-2028.
2. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, Tracy RP, Van Wagoner DR, Psaty BM, Lauer MS, Chung MK. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003;108: 3006-3010.
3. Oral H, Chugh A, Ozaydin M, Good E, Fortino J, Sankaran S, Reich S, Igic P, Elmouchi D, Tschopp D, Wimmer A, Dey S, Crawford T, Pelosi F Jr, Jongnarangsin K, Bogun F, Morady F. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation. 2006;114: 759-765.
4. Lellouche N, Sacher F, Wright M, Nault I, Brottier J, Knecht S, Matsuo S, Lomas O, Hocini M, Haïssaguerre M, Jaïs P. Usefulness of C-reactive protein in predicting early and late recurrences after atrial fibrillation ablation. Europace. 2009;11: 662-664.
5. Katritsis D, Hossein-Nia M, Anastasakis A, Poloniecki I, Holt DW, Camm AJ, Ward DE, Rowland E. Use of troponin-T concentration and kinase isoforms for quantitation of myocardial injury induced by radiofrequency catheter ablation. Eur Heart J. 1997;18: 1007-1013.
6. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60: 1581-1598.
7. McCabe JM, Smith LM, Tseng ZH, Badhwar N, Lee BK, Lee RJ, Scheinman MM, Olgin JE, Marcus GM. Protracted crp elevation after atrial fibrillation ablation. Pacing Clin Electrophysiol. 2008;31: 1146-1151.
8. Rotter M, Jaïs P, Vergnes MC, Nurden P, Takahashi Y, Sanders P, Rostock T, Hocini M, Sacher F, Haïssaguerre M. Decline in C-reactive protein after successful ablation of long-lasting persistent atrial fibrillation. J Am Coll Cardiol. 2006;47: 1231-1233.
9. Koyama T, Sekiguchi Y, Tada H, Arimoto T, Yamasaki H, Kuroki K, Machino T, Tajiri K, Zhu XD, Kanemoto M, Sugiyasu A, Kuga K, Aonuma K. Comparison of characteristics and significance of immediate versus early versus no recurrence of atrial fibrillation after catheter ablation. Am J Cardiol. 2009;103: 1249-1254.
10. Richter B, Gwechenberger M, Socas A, Marx M, Gössinger HD. Frequency of recurrence of atrial fibrillation within 48 hours after ablation and its impact on long-Term outcome. Am J Cardiol. 2008;101: 843-847.
11. Lin YJ, Tsao HM, Chang SL, Lo LW, Tuan TC, Hu YF, Udyavar AR, Tsai WC, Chang CJ, Tai CT, Lee PC, Suenari K, Huang SY, Nguyen HT, Chen SA. Prognostic implications of the high-sensitive C-reactive protein in the catheter ablation of atrial fibrillation. Am J Cardiol. 2010;105: 495-501.
12. Willoughby SR, Roberts-Thomson RL, Lim HS, Schultz C, Prabhu A, De Sciscio P, Wong CX, Worthley MI, Sanders P. Atrial platelet reactivity in patients with atrial fibrillation. Heart Rhythm. 2010;7: 1178-1183.
13. Madrid AH, del Rey JM, Rubí J, Ortega J, González Rebollo JM, Seara JG, Ripoll E, Moro C. Biochemical markers and cardiac troponin I release after radiofrequency catheter ablation: approach to size of necrosis. Am Heart J. 1998;136: 948-955.
14. Knayzer B, Abramov D, Natalia B, Tovbin D, Ganiel A, Katz A. Atrial fibrillation and plasma troponin I elevation after cardiac surgery: relation to inflammation-Associated parameters. J Card Surg. 2007;22: 117-123.
15. Conway DS, Buggins P, Hughes E, Lip GY. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation. J Am Coll Cardiol. 2004;43: 2075-2082.
16. Sanders P, Morton JB, Kistler PM, Vohra JK, Kalman JM, Sparks PB. Reversal of atrial mechanical dysfunction after cardioversion of atrial fibrillation: implications for the mechanisms of tachycardia-mediated atrial cardiomyopathy. Circulation. 2003;108: 1976-1984.
17. Nakamura Y, Nakamura K, Fukushima-Kusano K, Ohta K, Matsubara H, Hamuro T, Yutani C, Ohe T. Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis. Thromb Res. 2003;111: 137-142.
18. Thambidorai SK, Parakh K, Martin DO, Shah TK, Wazni O, Jasper SE, Van Wagoner DR, Chung MK, Murray RD, Klein AL. Relation of c-reactive protein correlates with risk of thromboembolism in patients with atrial fibrillation. Am J Cardiol. 2004;94: 805-807.
19. Lim HS, Willoughby SR, Schultz C, Gan C, Alasady M, Lau DH, Leong DP, Brooks AG, Young GD, Kistler PM, Kalman JM, Worthley MI, Sanders P. Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm. J Am Coll Cardiol. 2013;61: 852-860.
20. Vene N, Mavri A, Kosmelj K, Stegnar M. High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy. Thromb Haemost. 2003;90: 1163-1172.
21. Koyama T, Tada H, Sekiguchi Y, Arimoto T, Yamasaki H, Kuroki K, Machino T, Tajiri K, Zhu XD, Kanemoto-Igarashi M, Sugiyasu A, Kuga K, Nakata Y, Aonuma K. Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation: a randomized controlled trial. J Am Coll Cardiol. 2010;56: 1463-1472.
22. Deftereos S, Giannopoulos G, Kossyvakis C, Efremidis M, Panagopoulou V, Kaoukis A, Raisakis K, Bouras G, Angelidis C, Theodorakis A, Driva M, Doudoumis K, Pyrgakis V, Stefanadis C. Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study. J Am Coll Cardiol. 2012;60: 1790-1796.
23. Nascimento T, Mota F, dos Santos LF, de Araujo S, Okada M, Franco M, de Paola A, Fenelon G. Impact of prophylactic corticosteroids on systemic inflammation after extensive atrial ablation in pigs. Europace. 2012;14: 138-145.